In this paper we derive locally D-and ED p -optimal designs for the exponential, log-linear and three parameter EMAX-model. We show that for each model the locally D-and ED p -optimal designs are supported at the same set of points, while the corresponding weights are dierent. This indicates that for a given model, Doptimal designs are ecient for estimating the smallest dose which achieves 100p% of the maximum eect in the observed dose range. Conversely, ED p -optimal designs also yield good D-eciencies. We illustrate the results using several examples and demonstrate that locally D-and ED p -optimal designs for the EMAX-, log-linear and exponential model are relatively robust with respect to misspecication of the model parameters.
Introduction
The EMAX, log-linear and exponential models are widely used in various applications, especially in modeling the relationship between response and a given dose. These three models reect dierent potential response shapes. For example, one may assume that the dose-response relationship of a drug is increasing and has a maximum eect which is achieved asymptotically at large dose levels. This is reected by the EMAX model f (x, θ) = θ 0 + θ 1 x x + θ 2 , where x denotes the dose, θ 0 the placebo eect at dose d = 0, θ 1 the asymptotic maximum treatment benet over placebo and θ 2 the dose that gives half of the asymptotic maximum eect. In particular, the E max can be justied on the relationship of drug-receptor interactions and therefore deduced from the chemical equilibrium equation [1] .
The log-linear model describes the relationship between the dose of a drug and its eect, where the eect increases linearly in the logarithm of dose, that is f (x, θ) = θ 0 + θ 1 log(x + θ 2 ).
Here θ 0 denotes the placebo eect and θ 1 denes the increase of log(x + θ 2 ), where θ 2 is an additive constant to avoid diculties with the logarithm when the placebo response is zero. A dierence between the EMAX and the log-linear model is that the latter produces an unbounded eect, as dose approaches innity. For example, [24] used the log-linear model to relate the synthesis rate of prothrombin complex activity to the plasma concentration of warfarin; see [22] for further applications. Relationships of dose and eect, which have a sublinear or convex structure, are described by the exponential model f (x, θ) = θ 0 + θ 1 exp (x/θ 2 )
where θ 0 denotes the placebo eect, θ 1 the slope of the curve and θ 2 determines the rate of eect increase. We refer to [13] and [25] for application of this model in quantitative risk assessment and clinical dose nding studies, respectively. Because of the broad applicability of these models, especially in the development of a new compound, such as a drug or a fertilizer, the availability of ecient experimental designs employing the EMAX, log-linear and exponential model is important. Good designs can substantially improve the eciency of statistical analyses. Optimal designs for the EMAX model with two parameters (i.e. E 0 = 0) have been discussed by numerous authors [see for example Dunn (1988) , Rasch (1990) , Song and Wong (1998) In Section 2 we motivate the methods described in this paper with an example of a clinical dose nding study. In Section 3 we briey introduce the necessary notation. In Section 4 we determine locally D-optimal designs for the three parameter EMAX and log-linear model. For the exponential model these designs have been found in Dette and Neugebauer (1997), Han and Chaloner (2003) and Dette, Martinez Lopez, Ortiz Rodrguez and Pepelyshev (2006). In Section 5 we consider locally optimal designs for estimating the ED p for the three models, where the ED p is dened as the smallest dose achieving 100p% of the maximum eect in the observed dose range. We demonstrate that in each of the three models the locally D-and ED p -optimal designs are supported at the same points: the two boundary points of the design interval and one interior point depending on the model under consideration. Interestingly, the support points of locally D-and ED p -optimal designs coincide with the interior support points of the locally optimal design for estimating the minimum eective dose (M ED), if this design is supported at three points [see Dette, Bretz, Pepelyshev and Pinheiro (2008) ]. This indicates that D-optimal designs are relatively ecient for estimating the M ED and ED p in the EMAX, log-linear and exponential model and vice versa. This is conrmed by several examples in Section 6. There we also demonstrate that locally optimal designs are relatively sensitive with respect to misspecication of the underlying model. On the other hand, if a given model can be justied (for example by previous trials or pharmacokinetic data) we demonstrate that locally D-and ED p -optimal designs are robust with respect to misspecication of the model parameters.
A clinical dose nding study
To illustrate and motivate the methods described in this paper, we consider a clinical dose nding study for an anti-anxiety drug . The primary endpoint is the . Note that all models are normalized such that the maximum response value is given by 0.4. The maximum eect within the dose range under investigation is attained at the maximum dose level x max = 150mg. The corresponding curves are depicted in Figure 2 .1. This Figure shows also the ED p with p = 0.5 for the three models. We will use these models and corresponding parameter values to motivate and illustrate later the methodological developments of this paper. The remaining key questions at the design stage involve the determination of the necessary number of dierent dose levels, the location of the dose levels within the dose range, and the proportions of patients to be allocated to each of the dose levels, such that the ED p can be estimated eciently for any of the candidate models. In addition, we derive D-optimal designs for each of the models from Table 2.1. The original considerations for the example study led to a design with dose levels 0, 10, 25, 50, 100, and 150mg and a total sample size of 300 patients equally allocated to each of the six parallel treatment groups. This design corresponds to current pharmaceutical practice, which typically employs an equal allocation of the patients to the dose levels under investigation. The dose levels themselves are often chosen such that they are approximately equidistributed on a logarithmic scale, that is, a given dose level is approximately twice as large as the next lower dose level. Throughout this paper we call this the standard design. Designs of this type can be improved when using the methods proposed in this paper.
Notation
The three dierent nonlinear dose-response regression models described in the Introduction can be written in the general form
where Y is the observation at experimental condition
T denotes the vector of unknown parameters and the expected response E(Y |x) is at a given x
We assume the explanatory variable x varies in the interval V = [a, b], where 0 ≤ a < b and normally distributed observations are available at each x ∈ V with mean f (x, θ) and variance σ 2 > 0. The non-linear regression function f is either f 1 , f 2 or f 3 and the observations are assumed to be independent. An experimental design ξ is a probability measure with nite support dened on the set V [see Kiefer (1974) ]. The information matrix of an experimental design ξ is dened by
where
denotes the gradient of the expected response with respect to the parameter θ. If N observations are available and the design ξ concentrates masses w i at the points x i , i = 1, . . . , n, the quantities w i N are rounded to integers such that (ξ, θ), provided that the inverse of the information matrix exists [see Jennrich (1969) ]. An optimal experimental design maximizes or minimizes an appropriate functional of the information matrix or its inverse. There are numerous optimality criteria which can be used to discriminate between competing designs [see Silvey (1980) and Pukelsheim (1993) ]. In this paper we investigate (i) the D-optimality criterion, which maximizes the determinant of the inverse of the information matrix with respect to the design ξ (Section 4) and (ii) the ED p -optimality criterion, which is a special case of the c-optimality (Section 5). It is remarkable that for the three models considered here the locally D-and ED p -optimal designs on the design space V = [a, b] have the same structure, that is
where the point x * depends on the regression model but not on the optimality criterion.
While the D-optimal designs are equally weighted (i.e. w 1 = w 2 = w 3 ), ED p -optimal designs are not; their weights are given in Section 5.
Locally D-optimal designs
In this section we study D-optimal designs. For the non-linear regression models (3.2a), (3.2b) and (3.2c) the vectors of the partial derivatives are given by
respectively. The following result yields the general structure of the locally D-optimal designs. The explicit designs are given in Theorem 4.2. . First, we show that n = 3. Next, we will show that the locally D-optimal design contains the boundary points a and b. This completes the proof. Obviously, we have n ≥ 3, because the information matrix M (ξ * D , θ) of a locally D-optimal design is nonsingular. The gradient of the regression function (3.2a) with respect to the parameter θ = (θ 0 , θ 1 , θ 2 ) is given by (4.1a), which yields the variance function
at the experimental condition x ∈ V. This function has the form
with some coecients α 1 , . . . , α 5 . The specic relation between the coecients α i and the parameters is not of interest in the following discussion. Because the diagonal elements of M 
When multiplying (4.3a) and (4.3b) by (x + θ 2 )
4 , the required constraints on the variance function can be reformulated as
where P 4 (x) is an appropriate polynomial of degree 4 with positive leading coecient. Assume that n > 3 holds, i.e. the design has more than 3 support points on the design space V = [a, b]. Then the polynomial P 4 (x) has at least 4 roots in the interval [a, b] . From the characteristics of P 4 (x) mentioned in (4.4a) and (4.4b) and the positivity of the leading coecient, the polynomial P 4 (x) has at least two zeros of order 1 and two zeros of order 2, which contradicts to the fact that the degree of P 4 (x) is 4. Next we show that the locally D-optimal design contains the boundary points a and b. For this purpose we assume the contrary, i.e. a is not a support point of the design. Then the polynomial P 4 (x) has two roots in the interior of the interval [a, b] and one root equals b or it has three roots in the interior of [a, b] . A polynomial with three roots satisfying the constraints (4.4a) and (4.4b) has at least two zeros of order 2 and one zero of order 1, which again leads to a contradiction. Similar arguments hold for the boundary point b.
The following result shows that the D-optimal designs for the three models are equally weighted. In addition, we present the explicit expressions for the interior support point x * for each of the three models. 
for the EMAX model (3.2a),
for the log-linear model (3.2b) and
for the exponential model (3.2c).
Proof: We only present the proof for the EMAX model, because the other two cases can be treated similarly. From Theorem 4.1 we know that a locally D-optimal design for the EMAX model is supported at three points, including the two boundary points a and b of the design space. It is easy to see that a locally D-optimal design has equal weights on its support points, i.e. w i = 1/3 for i = 1, 2, 3 [see Silvey (1980) ]. Thus, we need to prove that the interior support point has the form (4.5). Based on the denition of the information matrix (3.3) it follows
where g 1 (x, θ) is given in (4.1a). Straightforward calculation yields the determinant of the information matrix
In order to maximize T (x, θ) we determine the roots of the derivative
and obtain 
Locally ED p -optimal designs
The ED p , 0 < p < 1, is the smallest dose achieving 100p% of the maximum eect in the observed dose range [a, b] (Bretz et al. (2008)). Let h(x, θ) = f (x, θ) − f (a, θ), where f (x, θ) is a parameterisation of the form (3.1). The ED p can be dened as
Here , x max denotes the dose at which the maximum expected response is observed. Because f (x, θ) is increasing for the models under consideration we have x max = b, which does not depend on the parameters θ 0 and θ 1 . Using (5.1) we can express the ED p in terms of the underlying model parameter, that is
Evidently, ifθ denotes the maximum likelihood estimate for the parameter θ, the statistic β(θ) is an estimator for ED p with asymptotic variance
where c(θ) = ∂ ∂θ β(θ) denotes the gradient of the function β with respect to θ and M − (ξ, θ) denotes a generalized inverse of the information matrix M (ξ, θ) dened in (3.3). Hence, an appropriate choice of an optimality criterion for a precise ED p estimation is given by
(θ).
A locally ED p -optimal design minimizes the function Ψ EDp in the class of all designs for which c(θ) is estimable, that is c(θ) ∈ Range(M (ξ, θ)). Note that for the three models under consideration the gradient does not depend on the parameters θ 0 and θ 1 and consequently the vector c(θ) has the form
for some constant γ. The following results give the locally ED p -optimal designs for three models under consideration. Proof: We restrict the proof to the EMAX model, because the other cases can be treated similarly. The EMAX model is of the form (3.2a) and the gradient of the regression function f (x, θ) with respect to the parameter θ = (θ 0 , θ 1 , θ 2 ) is given by (4.1a). In order to determine the number of support points of the locally ED p -optimal design, we rst show that the functions 1,
constitute a Chebychev-system [see Karlin and Studden (1966) ]. This property holds because for all y 1 , y 2 , y 3 ∈ V = [a, b] ⊆ R ≥0 with y 1 < y 2 < y 3 we have
Because the regression function f (x, θ) is strictly increasing, x max = b and the ED p is given by
Therefore, it follows that
On the other hand, we have
and it follows from Studden (1968) that the ED p -optimal design is supported at exactly three points. Moreover, it also holds that
Hence, based on a result from Karlin and Studden (1966) , the support points are given by three points including the boundary points of the design space.
In the following we present the explicit expressions for the interior support point x * and the weights for each of the three models.
Theorem 5.2 The locally ED p -optimal design ξ * ED p on the design space V = [a, b] is of the form (3.5) with weight w 2 = 1/2. The interior support point x * and the weight w 1 of the left boundary point of the design space are given by
Proof: Again, only a proof for the EMAX model is given. The corresponding results for the log-linear and exponential model are shown similarly. According to Theorem 5.1 the locally ED p -optimal design ξ * ED p on the design space V = [a, b] has exactly three support points, where two of them are the boundary points a and b of the design interval. Next, we use Elfving's theorem [see Elfving (1952) ] to determine the weights w 1 , w 2 and w 3 (note that the ED p -optimality is a special case of c-optimality). For this purpose we dene the Elfving set by
where conv (A) denotes the convex hull of a set A. It follows from Elfving's Theorem that the design ξ * ED p is locally ED p -optimal and minimizes c . Hence, the following system of equations has to be solved.
ρ(c)
Choosing ε 1 = ε 3 = 1 and ε 2 = −1 and replacing w 3 by 1 − w 1 − w 2 leads to w 2 = 1/2 because of (5.7). Inserting ω 2 into (5.8) results in
Hence the weight ω 1 is given by (5.9)
and with ω 3 = 1 − ω 1 − ω 2 it follows that (5.10)
In order to calculate the remaining support point x * EM AX , we insert these weights in the criterion function
and minimize it. Using a straightforward calculation, this function can be simplied to
The derivative of this criterion with respect to x is given by
The pointx is not an element of the design space V = [a, b] and therefore not admissible. Hence,x is the point where Ψ ED p is minimal, because the criterion function is convex on the design space. Letting p = θ 2 +b 2θ 2 +a+b , it follows thatx = ap + b(1 − p) which implies that a <x < b. Therefore, the remaining support point is given byx = x * EM AX and insertinḡ x in (5.9) and (5.10) gives the corresponding weights
Consequently, by Elfving's Theorem, the design with masses w 1 = 1/4, w 2 = 1/2 and w 3 = 1/4 at the points a, x * EM AX and b, respectively, is locally ED p -optimal.
Examples and eciency considerations
In this section we rst use the results from Sections 4 and 5 to compute D-and ED poptimal designs for the three models described in the example in Section 2. Then we analyse the robustness of the locally optimal designs with respect to misspecication of the model or model parameters. We further investigate the ED p -eciency of a locally Doptimal design and vice versa. Furthermore we compare the standard design from Section 2 with the locally optimal designs.
The D-eciency of a design ξ is dened by
, where ξ * D denotes the locally D-optimal design. Accordingly, the ED p -eciency is dened by
where c T (θ) = γ(0, 0, 1) and ξ * EDp denotes the locally ED p -optimal design (note that eff EDp (ξ) does not depend on γ). In the following we investigate the D-and ED p -eciencies for the three dose response models from Table 2.1. In order to investigate the loss of eciency caused by a misspecication of the underlying model, we compare the eciency of the locally D-and ED p -optimal designs provided that one specic model is the true one. Using the results from Sections 4 and 5, the locally Dand ED p -optimal designs with respect to the parameters specied in Table 2 .1 are given by Table 6 .1 are interpreted similarly. In general, we note that D-optimal designs are very sensitive with respect to the model assumptions. The eciency is particularly poor if a locally D-optimal design for the log-linear model is used under a true exponential model. The ED p -eciencies Table 6 .2, and vary between 0.23% to from Section 2. We compare this standard design with the optimal designs ξ *
• for the three dierent models by computing their eciencies; see Table 6 .3 and 6.4 for the results under the log-linear model. As the results for the other two models are similar, they are omitted.
The last column of Table 6 .3 (respectively Table 6 .4) shows the eciencies of the standard design ξ S for dierent values of θ 1 and θ 2 . It is remarkable that the eciency depends only on the parameter θ 2 and varies from 66% to 72% for the D-optimality criterion and from 38% to 51% for the ED p -optimality criterion. Because the information matrix M (ξ, θ) does not depend on θ 0 , the criteria functions are linear in θ 1 and the vector c(θ) is independent of θ 0 and θ 1 , and so is the eciency independent of θ 0 and θ 1 .
An additional question involves the robustness of the locally optimal designs under variation of the optimality criterion: How ecient is a locally ED p -optimal design under The last row presents the eciency of the standard design ξ S dened by (6.6). Table 6 .5 the eciencies are presented for the EMAX model; for the other two models the values are similar. We observe that the two designs are relatively robust with respect to the choice of the optimality criterion.
The ED p -eciency of the locally D-optimal design is 89% and 95% vice versa. This is because for the models under consideration the ED p -optimality criterion reduces to the D 1 -optimality criterion (a criterion for precise estimation of θ 2 ), i.e.
whereM (ξ, θ) denotes the matrix obtained from M (ξ, θ) by deleting the last row and column. Consequently, minimizing
Finally, we investigate the robustness of locally optimal designs under parameter misspecication: How does the eciency of a design change if the initial parameters estimates dier from the true parameter values? In Figure 6 .1 a contourplot shows the eciency of a design with parameters θ 1 ∈ [0.2, 0.7] and θ 2 ∈ [10, 35] under the assumption that the true parameters are θ 1 = 0.467 and θ 2 = 25. The underlying model is the EMAX-model, but the results for the two other models are similar. Remarkably, the D-eciency does not change substantially and the ED p -eciency remains in a relatively wide area greater than 80%. In other words, the locally D-and ED p -optimal designs are robust with respect to (moderate) misspecications of the unknown parameters.
Conclusions
This article focused on the derivation of locally D-and ED p -optimal designs for a class of common non-linear regression models (exponential, log-linear and three parameter EMAXmodel). These models are often applied in dose nding studies conducted in the development of a new compound, such as a medicial drug or a fertilizer. We derived optimal designs, which, under a particular model, (i) minimize the asymptotic variance of the ED p estimate or (ii) maximize the determinant of the inverse of the information matrix. We showed that for each model the locally D-and ED p -optimal designs are supported at the same set of points, while the corresponding weights are dierent. We used a real clinical dose nding study to investigate the properties of these designs. As expected by the theoretical results, D-optimal designs are ecient for estimating the ED p under a given model, and conversely ED p -optimal designs also yield good D-eciencies. We further showed that the derived designs are moderately robust with respect to an initial misspecication of the model parameters. The sensitivity of the optimality results to the prespecied dose response model is apparently more severe. If in practice the knowledge about the underlying model is limited, Bayesian or standardized maximin-optimal designs may be considered, which robustify the locally optimal designs considered here with respect to model and parameter misspecication, see Dette et al. (2008) for an application.
